Dr Sarra Ryan
Dr Ed Schwalbe
Mike Cole
Yuan Lu
Dr Meryl Lusher
et al. | MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma | 2012 |
Dr Ed Schwalbe
Dr Janet Lindsey
Dr Daniel Williamson
Dr David Hamilton
Kieran O'Toole
et al. | Epigenetic sub-classification and risk-stratification of medulloblastoma using DNA methylomics | 2012 |
Professor Steven Clifford
Professor David Ellison
Dr Richard Gilbertson
| Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas | 2012 |
Professor Steven Clifford
Professor David Ellison
Dr Richard Gilbertson
| Molecular subgroups of medulloblastoma: the current consensus | 2012 |
Professor David Ellison
Dr Hisham Megahed
Dr Meryl Lusher
Dr Sarra Ryan
Professor Simon Bailey
et al. | Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables | 2011 |
Professor David Ellison
Sarah Nicholson
Professor Simon Bailey
Professor Steven Clifford
Dr Richard Gilbertson
et al. | Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups | 2011 |
Dr Ed Schwalbe
Dr Janet Lindsey
Debbie Straughton
Mike Cole
Dr Hisham Megahed
et al. | Rapid Diagnosis of Medulloblastoma Molecular Subgroups | 2011 |
Dr Janet Lindsey
Dr Rebecca Hill
Dr Hisham Megahed
Dr Meryl Lusher
Dr Ed Schwalbe
et al. | TP53 Mutations in Favorable-Risk Wnt/Wingless-Subtype Medulloblastomas | 2011 |
Professor David Ellison
Dr Hisham Megahed
Dr Sarra Ryan
Dr Meryl Lusher
Sarah Nicholson
et al. | Clinical, pathological, and molecular variables define risk-stratification groups in childhood medulloblastoma | 2010 |
Dr Vikki Rand
Professor David Ellison
Dr Richard Gilbertson
| Cross-species genomics matches driver mutations and cell compartments to model ependymoma | 2010 |
